{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T14:29:33Z","timestamp":1791210573169,"version":"4.1.0"},"reference-count":259,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2016,1,1]],"date-time":"2016-01-01T00:00:00Z","timestamp":1451606400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","award":["DE018184"],"award-info":[{"award-number":["DE018184"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","translationalres.com","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Translational Research"],"published-print":{"date-parts":[[2016,1]]},"DOI":"10.1016\/j.trsl.2015.06.017","type":"journal-article","created":{"date-parts":[[2015,7,5]],"date-time":"2015-07-05T11:32:47Z","timestamp":1436095967000},"page":"257-280","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":235,"title":["Targeting inflammation in metabolic syndrome"],"prefix":"10.1016","volume":"167","author":[{"given":"Francine K.","family":"Welty","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdulhamied","family":"Alfaddagh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tarec K.","family":"Elajami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.trsl.2015.06.017_bib1","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1001\/archinte.159.10.1104","article-title":"Clustering of metabolic factors and coronary heart disease","volume":"159","author":"Wilson","year":"1999","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.trsl.2015.06.017_bib2","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1161\/CIRCULATIONAHA.109.192644","volume":"120","author":"Alberti","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.trsl.2015.06.017_bib3","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1001\/jama.287.3.356","article-title":"Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey","volume":"287","author":"Ford","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.trsl.2015.06.017_bib4","series-title":"The metabolic and molecular bases of inherited disease","first-page":"1841","article-title":"Introduction: structure and metabolism of plasma lipoproteins","author":"Havel","year":"1995"},{"key":"10.1016\/j.trsl.2015.06.017_bib5","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.cmet.2013.10.006","article-title":"Resolvins, specialized proresolving lipid mediators, and their potential roles in metabolic diseases","volume":"19","author":"Spite","year":"2014","journal-title":"Cell Metab"},{"key":"10.1016\/j.trsl.2015.06.017_bib6","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1038\/nri2925","article-title":"Type 2 diabetes as an inflammatory disease","volume":"11","author":"Donath","year":"2011","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.trsl.2015.06.017_bib7","doi-asserted-by":"crossref","first-page":"48115","DOI":"10.1074\/jbc.M209459200","article-title":"Serine phosphorylation of insulin- receptor substrate 1 by inhibitor kappa B kinase complex","volume":"277","author":"Gao","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1016\/j.trsl.2015.06.017_bib8","doi-asserted-by":"crossref","first-page":"35375","DOI":"10.1074\/jbc.M806480200","article-title":"S6K directly phosphorylates IRS-1 on Ser-270 to promote insulin resistance in response to TNF-(alpha) signaling through IKK2","volume":"283","author":"Zhang","year":"2008","journal-title":"J Biol Chem"},{"key":"10.1016\/j.trsl.2015.06.017_bib9","first-page":"3257","article-title":"Insulin inhibits intranuclear nuclear factor kappaB and stimulates IkappaB in mononuclear cells in obese subjects: evidence for an anti-inflammatory effect?","volume":"86","author":"Dandona","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.trsl.2015.06.017_bib10","first-page":"192","article-title":"The role of superoxide radical in TNF-alpha induced NF-kappaB activation","volume":"29","author":"Wang","year":"1999","journal-title":"Ann Clin Lab Sci"},{"key":"10.1016\/j.trsl.2015.06.017_bib11","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1530\/eje.0.1480293","article-title":"The role of the novel adipocyte-derived hormone adiponectin in human disease","volume":"148","author":"Diez","year":"2003","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.trsl.2015.06.017_bib12","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1007\/s00109-002-0378-7","article-title":"Adiponectin: a link between excess adiposity and associated comorbidities?","volume":"80","author":"Ukkola","year":"2002","journal-title":"J Mol Med (Berl)"},{"key":"10.1016\/j.trsl.2015.06.017_bib13","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1172\/JCI64941","article-title":"Direct control of hepatic glucose production by interleukin-13 in mice","volume":"123","author":"Stanya","year":"2013","journal-title":"J Clin Invest"},{"key":"10.1016\/j.trsl.2015.06.017_bib14","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1111\/j.1478-3231.2005.01087.x","article-title":"Effect of IL-4 and IL-13 on collagen production in cultured LI90 human hepatic stellate cells","volume":"25","author":"Sugimoto","year":"2005","journal-title":"Liver Int"},{"key":"10.1016\/j.trsl.2015.06.017_bib15","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1038\/nrm2391","article-title":"Adipocyte dysfunctions linking obesity to insulin resistance and type 2 diabetes","volume":"9","author":"Guilherme","year":"2008","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/j.trsl.2015.06.017_bib16","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/j.cmet.2012.04.001","article-title":"Inflammation and lipid signaling in the etiology of insulin resistance","volume":"15","author":"Glass","year":"2012","journal-title":"Cell Metab"},{"key":"10.1016\/j.trsl.2015.06.017_bib17","doi-asserted-by":"crossref","first-page":"35279","DOI":"10.1074\/jbc.M706762200","article-title":"A subpopulation of macrophages infiltrates hypertrophic adipose tissue and is activated by free fatty acids via Toll-like receptors 2 and 4 and JNK-dependent pathways","volume":"282","author":"Nguyen","year":"2007","journal-title":"J Biol Chem"},{"key":"10.1016\/j.trsl.2015.06.017_bib18","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1161\/CIRCULATIONAHA.105.591743","article-title":"Apolipoprotein CIII in apolipoprotein B lipoproteins enhances the adhesion of human monocytic cells to endothelial cells","volume":"113","author":"Kawakami","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.trsl.2015.06.017_bib19","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1161\/CIRCULATIONAHA.106.622514","article-title":"Apolipoprotein CIII induces expression of vascular cell adhesion molecule-1 in vascular endothelial cells and increases adhesion of monocytic cells","volume":"114","author":"Kawakami","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.trsl.2015.06.017_bib20","doi-asserted-by":"crossref","first-page":"3015","DOI":"10.1172\/JCI28898","article-title":"TLR4 links innate immunity and fatty acid-induced insulin resistance","volume":"116","author":"Shi","year":"2006","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.trsl.2015.06.017_bib21","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1016\/j.cell.2012.02.017","article-title":"Mechanisms for insulin resistance: common threads and missing links","volume":"148","author":"Samuel","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.trsl.2015.06.017_bib22","doi-asserted-by":"crossref","first-page":"36608","DOI":"10.1074\/jbc.M406499200","article-title":"Regulation of insulin action by ceramide: dual mechanisms linking ceramide accumulation to the inhibition of Akt\/protein kinase B","volume":"279","author":"Stratford","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1016\/j.trsl.2015.06.017_bib23","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1038\/ni.2022","article-title":"Fatty acid-induced NLRP3-ASC inflammasome activation interferes with insulin signaling","volume":"12","author":"Wen","year":"2011","journal-title":"Nat Immunol"},{"key":"10.1016\/j.trsl.2015.06.017_bib24","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1038\/ni.2228","article-title":"A role for the NLRP3 inflammasome in metabolic diseases\u2013did Warburg miss inflammation?","volume":"13","author":"Wen","year":"2012","journal-title":"Nat Immunol"},{"key":"10.1016\/j.trsl.2015.06.017_bib25","doi-asserted-by":"crossref","first-page":"2760","DOI":"10.1210\/me.2004-0429","article-title":"G protein-coupled receptor kinase 2 mediates endothelin-1-induced insulin resistance via the inhibition of both Galphaq\/11 and insulin receptor substrate-1 pathways in 3T3-L1 adipocytes","volume":"19","author":"Usui","year":"2005","journal-title":"Mol Endocrinol"},{"key":"10.1016\/j.trsl.2015.06.017_bib26","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s40292-013-0001-8","article-title":"G-protein-coupled receptor kinase 2 and hypertension: molecular insights and pathophysiological mechanisms","volume":"20","author":"Santulli","year":"2013","journal-title":"High Blood Press Cardiovasc Prev"},{"key":"10.1016\/j.trsl.2015.06.017_bib27","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1093\/cvr\/cvp252","article-title":"The G protein coupled receptor kinase 2 plays an essential role in beta-adrenergic receptor-induced insulin resistance","volume":"84","author":"Cipolletta","year":"2009","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.trsl.2015.06.017_bib28","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1161\/CIRCULATIONAHA.110.988642","article-title":"G protein-coupled receptor kinase 2 activity impairs cardiac glucose uptake and promotes insulin resistance after myocardial ischemia","volume":"123","author":"Ciccarelli","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.trsl.2015.06.017_bib29","doi-asserted-by":"crossref","first-page":"3053","DOI":"10.2337\/db12-1300","article-title":"Induction of cytosolic phospholipase a2alpha is required for adipose neutrophil infiltration and hepatic insulin resistance early in the course of high-fat feeding","volume":"62","author":"Hadad","year":"2013","journal-title":"Diabetes"},{"key":"10.1016\/j.trsl.2015.06.017_bib30","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/0929-7855(95)00012-F","article-title":"Cytosolic phospholipase A2","volume":"12","author":"Clark","year":"1995","journal-title":"J Lipid Mediat Cell Signal"},{"key":"10.1016\/j.trsl.2015.06.017_bib31","series-title":"Inflammation: basic principles and clinical correlates","author":"Gallin","year":"1999"},{"key":"10.1016\/j.trsl.2015.06.017_bib32","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1038\/270530a0","article-title":"Role of prostaglandin-mediated vasodilatation in inflammation","volume":"270","author":"Williams","year":"1977","journal-title":"Nature"},{"key":"10.1016\/j.trsl.2015.06.017_bib33","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1038\/nature01320","article-title":"Points of control in inflammation","volume":"420","author":"Nathan","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.trsl.2015.06.017_bib34","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.4049\/jimmunol.1203369","article-title":"Increased saturated fatty acids in obesity alter resolution of inflammation in part by stimulating prostaglandin production","volume":"191","author":"Hellmann","year":"2013","journal-title":"J Immunol"},{"key":"10.1016\/j.trsl.2015.06.017_bib35","doi-asserted-by":"crossref","first-page":"273","DOI":"10.2174\/1568010054022114","article-title":"Neutrophil-derived cytokines: potential therapeutic targets in inflammation","volume":"4","author":"Kasama","year":"2005","journal-title":"Curr Drug Targets Inflamm Allergy"},{"key":"10.1016\/j.trsl.2015.06.017_bib36","series-title":"Fundamentals of inflammation","article-title":"Neutrophils I","author":"Scher","year":"2010"},{"key":"10.1016\/j.trsl.2015.06.017_bib37","doi-asserted-by":"crossref","first-page":"3978","DOI":"10.4049\/jimmunol.0901355","article-title":"5-lipoxygenase activating protein signals adipose tissue inflammation and lipid dysfunction in experimental obesity","volume":"184","author":"Horrillo","year":"2010","journal-title":"J Immunol"},{"key":"10.1016\/j.trsl.2015.06.017_bib38","doi-asserted-by":"crossref","first-page":"4345","DOI":"10.4049\/jimmunol.174.7.4345","article-title":"Molecular circuits of resolution: formation and actions of resolvins and protectins","volume":"174","author":"Bannenberg","year":"2005","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.trsl.2015.06.017_bib39","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1161\/CIRCRESAHA.109.199570","article-title":"Defective phagocytosis of apoptotic cells by macrophages in atherosclerotic lesions of ob\/ob mice and reversal by a fish oil diet","volume":"105","author":"Li","year":"2009","journal-title":"Circ Res"},{"key":"10.1016\/j.trsl.2015.06.017_bib40","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1172\/JCI1578","article-title":"Neutrophil-mediated changes in vascular permeability are inhibited by topical application of aspirin-triggered 15-epi-lipoxin A4 and novel lipoxin B4 stable analogues","volume":"101","author":"Takano","year":"1998","journal-title":"J Clin Invest"},{"key":"10.1016\/j.trsl.2015.06.017_bib41","doi-asserted-by":"crossref","first-page":"14609","DOI":"10.1021\/bi00044a041","article-title":"Design of lipoxin A4 stable analogs that block transmigration and adhesion of human neutrophils","volume":"34","author":"Serhan","year":"1995","journal-title":"Biochemistry"},{"key":"10.1016\/j.trsl.2015.06.017_bib42","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1084\/jem.183.1.137","article-title":"Lipoxin A4 and B4 are potent stimuli for human monocyte migration and adhesion: selective inactivation by dehydrogenation and reduction","volume":"183","author":"Maddox","year":"1996","journal-title":"J Exp Med"},{"key":"10.1016\/j.trsl.2015.06.017_bib43","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.4049\/jimmunol.164.4.1663","article-title":"Cutting edge: lipoxins rapidly stimulate nonphlogistic phagocytosis of apoptotic neutrophils by monocyte-derived macrophages","volume":"164","author":"Godson","year":"2000","journal-title":"J Immunol"},{"key":"10.1016\/j.trsl.2015.06.017_bib44","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.immuni.2014.02.009","article-title":"Proresolving lipid mediators and mechanisms in the resolution of acute inflammation","volume":"40","author":"Buckley","year":"2014","journal-title":"Immunity"},{"key":"10.1016\/j.trsl.2015.06.017_bib45","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1084\/jem.192.8.1197","article-title":"Novel functional sets of lipid-derived mediators with antiinflammatory actions generated from omega-3 fatty acids via cyclooxygenase 2-nonsteroidal antiinflammatory drugs and transcellular processing","volume":"192","author":"Serhan","year":"2000","journal-title":"J Exp Med"},{"key":"10.1016\/j.trsl.2015.06.017_bib46","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1084\/jem.20020760","article-title":"Resolvins: a family of bioactive products of omega-3 fatty acid transformation circuits initiated by aspirin treatment that counter proinflammation signals","volume":"196","author":"Serhan","year":"2002","journal-title":"J Exp Med"},{"key":"10.1016\/j.trsl.2015.06.017_bib47","doi-asserted-by":"crossref","first-page":"14677","DOI":"10.1074\/jbc.M300218200","article-title":"Novel docosatrienes and 17S-resolvins generated from docosahexaenoic acid in murine brain, human blood, and glial cells.\u00a0Autacoids in anti-inflammation","volume":"278","author":"Hong","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1016\/j.trsl.2015.06.017_bib48","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1038\/89759","article-title":"Lipid mediator class switching during acute inflammation: signals in resolution","volume":"2","author":"Levy","year":"2001","journal-title":"Nat Immunol"},{"key":"10.1016\/j.trsl.2015.06.017_bib49","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1038\/9550","article-title":"Inducible cyclooxygenase may have anti-inflammatory properties","volume":"5","author":"Gilroy","year":"1999","journal-title":"Nat Med"},{"key":"10.1016\/j.trsl.2015.06.017_bib50","doi-asserted-by":"crossref","first-page":"E715","DOI":"10.1073\/pnas.1111600109","article-title":"Diabetes promotes an inflammatory macrophage phenotype and atherosclerosis through acyl-CoA synthetase 1","volume":"109","author":"Kanter","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.trsl.2015.06.017_bib51","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.jaut.2005.11.006","article-title":"A deficiency in the in\u00a0vivo clearance of apoptotic cells is a feature of the NOD mouse","volume":"26","author":"O'Brien","year":"2006","journal-title":"J\u00a0Autoimmun"},{"key":"10.1016\/j.trsl.2015.06.017_bib52","doi-asserted-by":"crossref","first-page":"2481","DOI":"10.2337\/diabetes.51.8.2481","article-title":"Phagocytosis of apoptotic cells by macrophages from NOD mice is reduced","volume":"51","author":"O'Brien","year":"2002","journal-title":"Diabetes"},{"key":"10.1016\/j.trsl.2015.06.017_bib53","doi-asserted-by":"crossref","first-page":"7250","DOI":"10.4049\/jimmunol.177.10.7250","article-title":"Chronic hyperglycemia predisposes to exaggerated inflammatory response and leukocyte dysfunction in Akita mice","volume":"177","author":"Gyurko","year":"2006","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.trsl.2015.06.017_bib54","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1146\/annurev.nutr.20.1.663","article-title":"The role of the microsomal triglyceride transfer protein in abetalipoproteinemia","volume":"20","author":"Berriot-Varoqueaux","year":"2000","journal-title":"Annu Rev Nutr"},{"key":"10.1016\/j.trsl.2015.06.017_bib55","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1172\/JCI115339","article-title":"Lipolysis exposes unreactive endogenous apolipoprotein E-3 in human and rat plasma very low density lipoprotein","volume":"88","author":"Sehayek","year":"1991","journal-title":"J Clin Invest"},{"key":"10.1016\/j.trsl.2015.06.017_bib56","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.cmet.2007.02.002","article-title":"Glycosylphosphatidylinositol-anchored high-density lipoprotein-binding protein 1 plays a critical role in the lipolytic processing of chylomicrons","volume":"5","author":"Beigneux","year":"2007","journal-title":"Cell Metab"},{"key":"10.1016\/j.trsl.2015.06.017_bib57","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1042\/CS20070308","article-title":"Apolipoprotein C-III: understanding an emerging cardiovascular risk factor","volume":"114","author":"Ooi","year":"2008","journal-title":"Clin Sci (Lond)"},{"key":"10.1016\/j.trsl.2015.06.017_bib58","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1161\/CIRCULATIONAHA.109.875807","article-title":"Apolipoprotein C-III and the metabolic basis for hypertriglyceridemia and the dense\u00a0low-density lipoprotein phenotype","volume":"121","author":"Zheng","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.trsl.2015.06.017_bib59","first-page":"163","article-title":"Hypertriglyceridemia: a review beyond low-density lipoprotein","volume":"10","author":"Rapp","year":"2002","journal-title":"Cardiology"},{"key":"10.1016\/j.trsl.2015.06.017_bib60","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1161\/CIRCRESAHA.108.178426","article-title":"Toll-like receptor 2\u00a0mediates apolipoprotein CIII-induced monocyte activation","volume":"103","author":"Kawakami","year":"2008","journal-title":"Circ Res"},{"key":"10.1016\/j.trsl.2015.06.017_bib61","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1161\/01.ATV.0000066131.01313.EB","article-title":"LDL containing apolipoprotein CIII is an independent risk factor for coronary events in diabetic patients","volume":"23","author":"Lee","year":"2003","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.trsl.2015.06.017_bib62","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1126\/science.1161524","article-title":"A null mutation in human APOC3 confers a favorable plasma lipid profile and apparent cardioprotection","volume":"322","author":"Pollin","year":"2008","journal-title":"Science"},{"key":"10.1016\/j.trsl.2015.06.017_bib63","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1056\/NEJMoa0907295","article-title":"Apolipoprotein C3 gene variants in nonalcoholic fatty liver disease","volume":"362","author":"Petersen","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.trsl.2015.06.017_bib64","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1373\/clinchem.2009.124669","article-title":"APOC3 mutation, serum triglyceride concentrations, and coronary heart disease","volume":"55","author":"Tsai","year":"2009","journal-title":"Clin Chem"},{"key":"10.1016\/j.trsl.2015.06.017_bib65","doi-asserted-by":"crossref","first-page":"4","DOI":"10.3389\/fendo.2014.00004","article-title":"Angiopoietin-like proteins: a comprehensive look","volume":"5","author":"Santulli","year":"2014","journal-title":"Front Endocrinol"},{"key":"10.1016\/j.trsl.2015.06.017_bib66","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1161\/ATVBAHA.113.301397","article-title":"Angptl3 deficiency is associated with increased insulin sensitivity, lipoprotein lipase activity, and decreased serum free fatty acids","volume":"33","author":"Robciuc","year":"2013","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.trsl.2015.06.017_bib67","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1517\/13543776.2013.842555","article-title":"Antibodies to human angiopoietin-like protein 3: a patent evaluation of WO2012174178","volume":"24","author":"Nakajima","year":"2014","journal-title":"Expert Opin Ther Pat"},{"key":"10.1016\/j.trsl.2015.06.017_bib68","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1053\/j.gastro.2007.11.038","article-title":"Alterations in adipose tissue and hepatic lipid kinetics in obese men and women with nonalcoholic fatty liver disease","volume":"134","author":"Fabbrini","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1016\/j.trsl.2015.06.017_bib69","doi-asserted-by":"crossref","first-page":"8854","DOI":"10.1016\/S0021-9258(19)38966-5","article-title":"Insulin modulation of hepatic synthesis and secretion of apolipoprotein B by rat hepatocytes","volume":"265","author":"Sparks","year":"1990","journal-title":"J Biol Chem"},{"issue":"Suppl","key":"10.1016\/j.trsl.2015.06.017_bib70","doi-asserted-by":"crossref","first-page":"S162","DOI":"10.1194\/jlr.R800090-JLR200","article-title":"The ever-expanding role of degradation in the regulation of apolipoprotein B metabolism","volume":"50","author":"Ginsberg","year":"2009","journal-title":"J Lipid Res"},{"key":"10.1016\/j.trsl.2015.06.017_bib71","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1161\/ATVBAHA.108.169383","article-title":"Triglyceride-rich lipoprotein-associated apolipoprotein C-III production is stimulated by plasma free fatty acids in humans","volume":"28","author":"Pavlic","year":"2008","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.trsl.2015.06.017_bib72","doi-asserted-by":"crossref","first-page":"24714","DOI":"10.1074\/jbc.274.35.24714","article-title":"Sterol regulatory element-binding protein negatively regulates microsomal triglyceride transfer protein gene transcription","volume":"274","author":"Sato","year":"1999","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.trsl.2015.06.017_bib73","doi-asserted-by":"crossref","first-page":"1946","DOI":"10.1161\/ATVBAHA.111.233049","article-title":"The complex metabolic mechanisms relating obesity to hypertriglyceridemia","volume":"31","author":"Eckel","year":"2011","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.trsl.2015.06.017_bib74","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1161\/01.ATV.0000057572.97137.DD","article-title":"Importance of different pathways of cellular cholesterol efflux","volume":"23","author":"Yancey","year":"2003","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.trsl.2015.06.017_bib75","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1126\/science.271.5248.460","article-title":"A docking receptor for HDL cholesterol esters","volume":"271","author":"Steinberg","year":"1996","journal-title":"Science"},{"key":"10.1016\/j.trsl.2015.06.017_bib76","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1172\/JCI5286","article-title":"Triglyceride enrichment of HDL enhances in\u00a0vivo metabolic clearance of HDL apo A-I in healthy men","volume":"103","author":"Lamarche","year":"1999","journal-title":"J Clin Invest"},{"key":"10.1016\/j.trsl.2015.06.017_bib77","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1002\/dmr.5610070303","article-title":"The role of the cholesteryl ester transfer protein in\u00a0lipoprotein metabolism","volume":"7","author":"Swenson","year":"1991","journal-title":"Diabetes Metab Rev"},{"key":"10.1016\/j.trsl.2015.06.017_bib78","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1161\/01.ATV.14.5.707","article-title":"Human HDL cholesterol levels are determined by apoA-I fractional catabolic rate, which correlates inversely with estimates of HDL particle size. Effects of gender, hepatic and lipoprotein lipases, triglyceride and insulin levels, and body fat distribution","volume":"14","author":"Brinton","year":"1994","journal-title":"Arterioscler Thromb"},{"key":"10.1016\/j.trsl.2015.06.017_bib79","doi-asserted-by":"crossref","first-page":"1806","DOI":"10.1161\/01.ATV.0000227472.70734.ad","article-title":"Reciprocal and coordinate regulation of serum amyloid A versus apolipoprotein A-I and paraoxonase-1 by inflammation in murine hepatocytes","volume":"26","author":"Han","year":"2006","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.trsl.2015.06.017_bib80","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1046\/j.1432-1327.1999.00657.x","article-title":"Serum amyloid A, the major vertebrate acute-phase reactant","volume":"265","author":"Uhlar","year":"1999","journal-title":"Eur J Biochem"},{"key":"10.1016\/j.trsl.2015.06.017_bib81","doi-asserted-by":"crossref","first-page":"30825","DOI":"10.1074\/jbc.M109.047605","article-title":"Modification of high density lipoprotein by myeloperoxidase generates a pro-inflammatory particle","volume":"284","author":"Undurti","year":"2009","journal-title":"J Biol Chem"},{"key":"10.1016\/j.trsl.2015.06.017_bib82","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S1050-1738(01)00095-0","article-title":"The role of high-density lipoproteins in oxidation and inflammation","volume":"11","author":"Van Lenten","year":"2001","journal-title":"Trends Cardiovasc Med"},{"key":"10.1016\/j.trsl.2015.06.017_bib83","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1161\/CIRCULATIONAHA.108.810721","article-title":"Inflammation impairs reverse cholesterol transport in\u00a0vivo","volume":"119","author":"McGillicuddy","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.trsl.2015.06.017_bib84","doi-asserted-by":"crossref","first-page":"2758","DOI":"10.1172\/JCI118345","article-title":"Anti-inflammatory HDL becomes pro-inflammatory during the acute phase response. Loss of protective effect of HDL against LDL oxidation in aortic wall cell cocultures","volume":"96","author":"Van Lenten","year":"1995","journal-title":"J Clin Invest"},{"key":"10.1016\/j.trsl.2015.06.017_bib85","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1194\/jlr.R400001-JLR200","article-title":"The oxidation hypothesis of atherogenesis: the role of oxidized phospholipids and HDL","volume":"45","author":"Navab","year":"2004","journal-title":"J Lipid Res"},{"key":"10.1016\/j.trsl.2015.06.017_bib86","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1002\/bies.201200044","article-title":"The lipid raft hypothesis revisited\u2013new insights on raft composition and function from super-resolution fluorescence microscopy","volume":"34","author":"Owen","year":"2012","journal-title":"Bioessays"},{"key":"10.1016\/j.trsl.2015.06.017_bib87","article-title":"T cells are active participants in the progression of atherosclerotic plaques","volume":"6","author":"Haraba","year":"2011","journal-title":"Dig J Nanomater Biostruct"},{"key":"10.1016\/j.trsl.2015.06.017_bib88","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.coph.2010.02.003","article-title":"Adaptive T cell immune responses and atherogenesis","volume":"10","author":"Taleb","year":"2010","journal-title":"Curr Opin Pharmacol"},{"key":"10.1016\/j.trsl.2015.06.017_bib89","doi-asserted-by":"crossref","first-page":"18","DOI":"10.3389\/fphys.2012.00018","article-title":"T cell costimulatory and coinhibitory pathways in vascular inflammatory diseases","volume":"3","author":"Lichtman","year":"2012","journal-title":"Front Physiol"},{"key":"10.1016\/j.trsl.2015.06.017_bib90","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1038\/nrcardio.2011.62","article-title":"Adaptive immunity in atherosclerosis: mechanisms and future therapeutic targets","volume":"8","author":"Lahoute","year":"2011","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.trsl.2015.06.017_bib91","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.atherosclerosis.2011.04.029","article-title":"Differential effects of regulatory T cells on the initiation and regression of atherosclerosis","volume":"218","author":"Foks","year":"2011","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.trsl.2015.06.017_bib92","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1038\/nm1343","article-title":"Natural regulatory T cells control the development of atherosclerosis in mice","volume":"12","author":"Ait-Oufella","year":"2006","journal-title":"Nat Med"},{"key":"10.1016\/j.trsl.2015.06.017_bib93","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1161\/CIRCULATIONAHA.110.006411","article-title":"Dynamic changes in regulatory T cells are linked to levels of\u00a0diet-induced hypercholesterolemia","volume":"124","author":"Maganto-Garcia","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.trsl.2015.06.017_bib94","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1038\/nm.2002","article-title":"Lean, but not obese, fat is enriched for a unique population of regulatory T cells that affect metabolic parameters","volume":"15","author":"Feuerer","year":"2009","journal-title":"Nat Med"},{"key":"10.1016\/j.trsl.2015.06.017_bib95","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1038\/nm.2353","article-title":"B cells promote insulin resistance through modulation of T cells and production of pathogenic IgG antibodies","volume":"17","author":"Winer","year":"2011","journal-title":"Nat Med"},{"key":"10.1016\/j.trsl.2015.06.017_bib96","doi-asserted-by":"crossref","first-page":"2637","DOI":"10.1161\/ATVBAHA.114.304636","article-title":"T-cell profile in adipose tissue is associated with insulin resistance and systemic inflammation in humans","volume":"34","author":"McLaughlin","year":"2014","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.trsl.2015.06.017_bib97","doi-asserted-by":"crossref","first-page":"36158","DOI":"10.1074\/jbc.M110.134130","article-title":"Apolipoprotein A-I modulates regulatory T cells in autoimmune LDLr-\/-, ApoA-I-\/- mice","volume":"285","author":"Wilhelm","year":"2010","journal-title":"J Biol Chem"},{"key":"10.1016\/j.trsl.2015.06.017_bib98","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1161\/ATVBAHA.108.183442","article-title":"Apolipoprotein A-I and its role in lymphocyte cholesterol homeostasis and autoimmunity","volume":"29","author":"Wilhelm","year":"2009","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.trsl.2015.06.017_bib99","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1093\/intimm\/dxs008","article-title":"CD4+ T-cell dysfunctions through the impaired lipid rafts ameliorate concanavalin A-induced hepatitis in sphingomyelin synthase 1-knockout mice","volume":"24","author":"Dong","year":"2012","journal-title":"Int Immunol"},{"key":"10.1016\/j.trsl.2015.06.017_bib100","doi-asserted-by":"crossref","first-page":"823","DOI":"10.5551\/jat.12823","article-title":"Apolipoprotein A-I inhibits CD40 proinflammatory signaling via ATP-binding cassette transporter A1-mediated modulation of lipid raft in macrophages","volume":"19","author":"Yin","year":"2012","journal-title":"J Atheroscler Thromb"},{"key":"10.1016\/j.trsl.2015.06.017_bib101","doi-asserted-by":"crossref","first-page":"e33917","DOI":"10.1371\/journal.pone.0033917","article-title":"Apolipoprotein A-I attenuates palmitate-mediated NF-kappaB activation by reducing Toll-like receptor-4 recruitment into lipid rafts","volume":"7","author":"Cheng","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.trsl.2015.06.017_bib102","doi-asserted-by":"crossref","first-page":"2561","DOI":"10.1161\/ATVBAHA.112.300135","article-title":"High density lipoprotein biogenesis, cholesterol efflux, and immune cell function","volume":"32","author":"Sorci-Thomas","year":"2012","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.trsl.2015.06.017_bib103","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1172\/JCI200418004","article-title":"HDL induces NO-dependent vasorelaxation via the lysophospholipid receptor S1P3","volume":"113","author":"Nofer","year":"2004","journal-title":"J Clin Invest"},{"key":"10.1016\/j.trsl.2015.06.017_bib104","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1172\/JCI16777","article-title":"HDL-associated estradiol stimulates endothelial NO synthase and vasodilation in an SR-BI-dependent manner","volume":"111","author":"Gong","year":"2003","journal-title":"J Clin Invest"},{"key":"10.1016\/j.trsl.2015.06.017_bib105","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/S1050-1738(03)00098-7","article-title":"HDL stimulation of endothelial nitric oxide synthase: a novel mechanism of HDL action","volume":"13","author":"Mineo","year":"2003","journal-title":"Trends Cardiovasc Med"},{"key":"10.1016\/j.trsl.2015.06.017_bib106","doi-asserted-by":"crossref","first-page":"6999","DOI":"10.1073\/pnas.0306266101","article-title":"High-density lipoprotein and apolipoprotein AI increase endothelial NO synthase activity by protein association and multisite phosphorylation","volume":"101","author":"Drew","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.trsl.2015.06.017_bib107","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1111\/j.1582-4934.2010.01045.x","article-title":"Apolipoprotein A-I possesses an anti-obesity effect associated with increase of energy expenditure and up-regulation of UCP1 in brown fat","volume":"15","author":"Ruan","year":"2011","journal-title":"J Cell Mol Med"},{"key":"10.1016\/j.trsl.2015.06.017_bib108","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1161\/CIRCULATIONAHA.108.843219","article-title":"High-density lipoprotein modulates glucose metabolism in patients with type 2 diabetes mellitus","volume":"119","author":"Drew","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.trsl.2015.06.017_bib109","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/S0968-0004(98)01340-1","article-title":"Dealing with energy demand: the AMP-activated protein kinase","volume":"24","author":"Kemp","year":"1999","journal-title":"Trends Biochem Sci"},{"key":"10.1016\/j.trsl.2015.06.017_bib110","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1172\/JCI13505","article-title":"Role of AMP-activated protein kinase in mechanism of metformin action","volume":"108","author":"Zhou","year":"2001","journal-title":"J Clin Invest"},{"key":"10.1016\/j.trsl.2015.06.017_bib111","doi-asserted-by":"crossref","first-page":"2261","DOI":"10.1161\/ATVBAHA.114.304131","article-title":"Apolipoprotein A-I increases insulin secretion and production from pancreatic beta-cells via a G-protein-cAMP-PKA-FoxO1-dependent mechanism","volume":"34","author":"Cochran","year":"2014","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.trsl.2015.06.017_bib112","doi-asserted-by":"crossref","first-page":"2328","DOI":"10.2337\/db07-0056","article-title":"Direct effect of cholesterol on insulin secretion: a novel mechanism for pancreatic beta-cell dysfunction","volume":"56","author":"Hao","year":"2007","journal-title":"Diabetes"},{"key":"10.1016\/j.trsl.2015.06.017_bib113","doi-asserted-by":"crossref","first-page":"2524","DOI":"10.1194\/jlr.M800238-JLR200","article-title":"Cholesterol accumulation and diabetes in pancreatic beta-cell-specific SREBP-2 transgenic mice: a new model for lipotoxicity","volume":"49","author":"Ishikawa","year":"2008","journal-title":"J Lipid Res"},{"key":"10.1016\/j.trsl.2015.06.017_bib114","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.bbrc.2008.11.105","article-title":"Nuclear SREBP-1a causes loss of pancreatic beta-cells and impaired insulin secretion","volume":"378","author":"Iwasaki","year":"2009","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.trsl.2015.06.017_bib115","doi-asserted-by":"crossref","first-page":"4521","DOI":"10.1210\/en.2009-0252","article-title":"Low- and high-density lipoproteins modulate function, apoptosis, and proliferation of primary human and murine pancreatic beta-cells","volume":"150","author":"Rutti","year":"2009","journal-title":"Endocrinology"},{"key":"10.1016\/j.trsl.2015.06.017_bib116","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1096\/fj.08-105734","article-title":"Insulin secretion is highly sensitive to desorption of plasma membrane cholesterol","volume":"23","author":"Vikman","year":"2009","journal-title":"FASEB J"},{"key":"10.1016\/j.trsl.2015.06.017_bib117","doi-asserted-by":"crossref","first-page":"292","DOI":"10.5551\/jat.E599","article-title":"Impaired insulin secretion in four Tangier disease patients with ABCA1 mutations","volume":"16","author":"Koseki","year":"2009","journal-title":"J Atheroscler Thromb"},{"key":"10.1016\/j.trsl.2015.06.017_bib118","doi-asserted-by":"crossref","first-page":"869","DOI":"10.2337\/dc09-1562","article-title":"Carriers of loss-of-function mutations in ABCA1 display pancreatic beta-cell dysfunction","volume":"33","author":"Vergeer","year":"2010","journal-title":"Diabetes Care"},{"key":"10.1016\/j.trsl.2015.06.017_bib119","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1111\/1440-1681.12315","article-title":"Metabolic remodelling in obesity and type 2 diabetes: pathological or protective mechanisms in response to nutrient excess?","volume":"42","author":"Connor","year":"2015","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"10.1016\/j.trsl.2015.06.017_bib120","doi-asserted-by":"crossref","first-page":"3143","DOI":"10.1161\/circ.106.25.3143","article-title":"Third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report","volume":"106","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.trsl.2015.06.017_bib121","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1056\/NEJMoa012512","article-title":"Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin","volume":"346","author":"Knowler","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.trsl.2015.06.017_bib122","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1126\/science.7678183","article-title":"Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance","volume":"259","author":"Hotamisligil","year":"1993","journal-title":"Science"},{"key":"10.1016\/j.trsl.2015.06.017_bib123","doi-asserted-by":"crossref","first-page":"2970","DOI":"10.1210\/jcem.85.8.6854","article-title":"Glucose challenge stimulates reactive oxygen species (ROS) generation by leucocytes","volume":"85","author":"Mohanty","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.trsl.2015.06.017_bib124","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1093\/ajcn\/80.1.51","volume":"80","author":"Aljada","year":"2004","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.trsl.2015.06.017_bib125","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1093\/ajcn\/75.4.767","article-title":"Both lipid and protein intakes stimulate increased generation of reactive oxygen species by polymorphonuclear leukocytes and mononuclear cells","volume":"75","author":"Mohanty","year":"2002","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.trsl.2015.06.017_bib126","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1093\/ajcn\/79.4.682","article-title":"Increase in intranuclear nuclear factor kappaB and decrease in inhibitor kappaB in mononuclear cells after a mixed meal: evidence for a proinflammatory effect","volume":"79","author":"Aljada","year":"2004","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.trsl.2015.06.017_bib127","first-page":"A405","article-title":"Absence of oxidative stress and inflammation following the intake of a 900 kcalorie meal rich in fruit and fiber","volume":"53","author":"Mohanty","year":"2004","journal-title":"Diabetes"},{"key":"10.1016\/j.trsl.2015.06.017_bib128","first-page":"355","article-title":"The suppressive effect of dietary restriction and weight loss in the obese on the generation of reactive oxygen species by leukocytes, lipid peroxidation, and protein carbonylation","volume":"86","author":"Dandona","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.trsl.2015.06.017_bib129","doi-asserted-by":"crossref","first-page":"2899","DOI":"10.1210\/jcem.86.6.7745","article-title":"Inhibitory effect of a two day fast on reactive oxygen species (ROS) generation by leucocytes and plasma ortho-tyrosine and meta-tyrosine concentrations","volume":"86","author":"Dandona","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.trsl.2015.06.017_bib130","doi-asserted-by":"crossref","first-page":"124","DOI":"10.2174\/187153010791213056","article-title":"Diet and metabolic syndrome","volume":"10","author":"Djousse","year":"2010","journal-title":"Endocr Metab Immune Disord Drug Targets"},{"key":"10.1016\/j.trsl.2015.06.017_bib131","doi-asserted-by":"crossref","first-page":"2957","DOI":"10.2337\/dc07-1231","article-title":"Mediterranean diet inversely associated with the incidence of metabolic syndrome: the SUN prospective cohort","volume":"30","author":"Tortosa","year":"2007","journal-title":"Diabetes Care"},{"key":"10.1016\/j.trsl.2015.06.017_bib132","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1161\/01.CIR.99.6.779","article-title":"Mediterranean diet, traditional risk factors, and the rate of cardiovascular complications after myocardial infarction: final report of the Lyon Diet Heart Study","volume":"99","author":"de Lorgeril","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.trsl.2015.06.017_bib133","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/j.numecd.2014.03.003","article-title":"Mediterranean dietary pattern, inflammation and endothelial function: a systematic review and meta-analysis of intervention trials","volume":"24","author":"Schwingshackl","year":"2014","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"10.1016\/j.trsl.2015.06.017_bib134","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.abb.2012.05.003","article-title":"Mediterranean diet polyphenols reduce inflammatory angiogenesis through MMP-9 and COX-2 inhibition in human vascular endothelial cells: a potentially protective mechanism in atherosclerotic vascular disease and cancer","volume":"527","author":"Scoditti","year":"2012","journal-title":"Arch Biochem Biophys"},{"key":"10.1016\/j.trsl.2015.06.017_bib135","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/j.nutres.2014.06.012","article-title":"Certain dietary patterns are beneficial for the metabolic syndrome: reviewing the evidence","volume":"34","author":"Calton","year":"2014","journal-title":"Nutr Res"},{"key":"10.1016\/j.trsl.2015.06.017_bib136","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1001\/jama.292.12.1440","article-title":"Effect of a Mediterranean-style diet on endothelial dysfunction and markers of vascular inflammation in the metabolic syndrome: a randomized trial","volume":"292","author":"Esposito","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.trsl.2015.06.017_bib137","doi-asserted-by":"crossref","first-page":"2823","DOI":"10.2337\/diacare.28.12.2823","article-title":"Beneficial effects of a Dietary Approaches to Stop Hypertension eating plan on features of the metabolic syndrome","volume":"28","author":"Azadbakht","year":"2005","journal-title":"Diabetes Care"},{"key":"10.1016\/j.trsl.2015.06.017_bib138","doi-asserted-by":"crossref","first-page":"726861","DOI":"10.1155\/2014\/726861","article-title":"Exercise induced adipokine changes and the metabolic syndrome","volume":"2014","author":"Golbidi","year":"2014","journal-title":"J Diabetes Res"},{"key":"10.1016\/j.trsl.2015.06.017_bib139","doi-asserted-by":"crossref","first-page":"2299","DOI":"10.1096\/fj.03-0269fje","article-title":"Peroxisome proliferator-activated receptor delta controls muscle development and oxidative capability","volume":"17","author":"Luquet","year":"2003","journal-title":"FASEB Journal"},{"key":"10.1016\/j.trsl.2015.06.017_bib140","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1507\/endocrj.KR-99","article-title":"New therapeutic target for metabolic syndrome: PPARdelta","volume":"54","author":"Takahashi","year":"2007","journal-title":"Endocr J"},{"key":"10.1016\/j.trsl.2015.06.017_bib141","doi-asserted-by":"crossref","first-page":"5306","DOI":"10.1073\/pnas.091021198","article-title":"A selective peroxisome proliferator-activated receptor delta agonist promotes reverse cholesterol transport","volume":"98","author":"Oliver","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.trsl.2015.06.017_bib142","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1194\/jlr.M400400-JLR200","article-title":"Reduced cholesterol absorption upon PPARdelta activation coincides with decreased intestinal expression of NPC1L1","volume":"46","author":"van der Veen","year":"2005","journal-title":"J Lipid Res"},{"key":"10.1016\/j.trsl.2015.06.017_bib143","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1161\/01.ATV.0000252790.70572.0c","article-title":"Triglyceride: high-density lipoprotein cholesterol effects in healthy subjects administered a peroxisome proliferator activated receptor delta agonist","volume":"27","author":"Sprecher","year":"2007","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.trsl.2015.06.017_bib144","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1007\/BF02693931","article-title":"PPAR delta agonists and metabolic diseases","volume":"9","author":"Kang","year":"2007","journal-title":"Curr Atheroscler Rep"},{"key":"10.1016\/j.trsl.2015.06.017_bib145","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1089\/ars.2008.2280","article-title":"PPARs and the\u00a0cardiovascular system","volume":"11","author":"Hamblin","year":"2009","journal-title":"Antioxid Redox Signal"},{"key":"10.1016\/j.trsl.2015.06.017_bib146","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1093\/jn\/135.8.1829","article-title":"Combination diet and exercise interventions for the treatment of dyslipidemia: an effective preliminary strategy to lower cholesterol levels?","volume":"135","author":"Varady","year":"2005","journal-title":"J Nutr"},{"key":"10.1016\/j.trsl.2015.06.017_bib147","first-page":"CD003817","article-title":"Exercise for overweight or obesity","author":"Shaw","year":"2006","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.trsl.2015.06.017_bib148","doi-asserted-by":"crossref","first-page":"2292","DOI":"10.1161\/CIR.0b013e3182160726","article-title":"Triglycerides and cardiovascular disease: a scientific statement from the American Heart Association","volume":"123","author":"Miller","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.trsl.2015.06.017_bib149","series-title":"The contribution of triglycerides and triglyceride-rich lipoproteins to atherosclerosis. Braunwald textbook of preventive cardiology","author":"Welty","year":"2011"},{"key":"10.1016\/j.trsl.2015.06.017_bib150","doi-asserted-by":"crossref","first-page":"2439","DOI":"10.1056\/NEJMra1008153","article-title":"n-3 fatty acids in cardiovascular disease","volume":"364","author":"De Caterina","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.trsl.2015.06.017_bib151","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1016\/S0022-2275(20)42339-9","article-title":"Effects of fish oil on VLDL triglyceride kinetics in humans","volume":"31","author":"Harris","year":"1990","journal-title":"J Lipid Res"},{"key":"10.1016\/j.trsl.2015.06.017_bib152","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1136\/heart.85.5.544","article-title":"An omega-3 polyunsaturated fatty acid concentrate administered for one year decreased triglycerides in simvastatin treated patients with coronary heart disease and persisting hypertriglyceridaemia","volume":"85","author":"Durrington","year":"2001","journal-title":"Heart"},{"key":"10.1016\/j.trsl.2015.06.017_bib153","doi-asserted-by":"crossref","first-page":"251","DOI":"10.2147\/vhrm.2006.2.3.251","article-title":"A review of omega-3 ethyl esters for cardiovascular prevention and treatment of increased blood triglyceride levels","volume":"2","author":"von Schacky","year":"2006","journal-title":"Vasc Health Risk Manag"},{"key":"10.1016\/j.trsl.2015.06.017_bib154","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1172\/JCI111422","article-title":"Suppression by diets rich in fish oil of very low density lipoprotein production in man","volume":"74","author":"Nestel","year":"1984","journal-title":"J Clin Invest"},{"key":"10.1016\/j.trsl.2015.06.017_bib155","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.chemphyslip.2008.02.007","article-title":"Docosahexaenoic acid (DHA) and hepatic gene transcription","volume":"153","author":"Jump","year":"2008","journal-title":"Chem Phys Lipids"},{"key":"10.1016\/j.trsl.2015.06.017_bib156","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1097\/MOL.0b013e3282ffaf6a","article-title":"N-3 polyunsaturated fatty acid regulation of hepatic gene transcription","volume":"19","author":"Jump","year":"2008","journal-title":"Curr Opin Lipidol"},{"key":"10.1016\/j.trsl.2015.06.017_bib157","doi-asserted-by":"crossref","first-page":"15184","DOI":"10.1073\/pnas.0510086103","article-title":"The omega-3 fatty acid docosahexaenoate attenuates endothelial cyclooxygenase-2 induction through both NADP(H) oxidase and PKC epsilon inhibition","volume":"103","author":"Massaro","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.trsl.2015.06.017_bib158","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s00232-005-0783-2","article-title":"Omega-3 fatty acids and the regulation of expression of endothelial pro-atherogenic and pro-inflammatory genes","volume":"206","author":"De Caterina","year":"2005","journal-title":"J Membr Biol"},{"key":"10.1016\/j.trsl.2015.06.017_bib159","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/j.atherosclerosis.2007.07.023","article-title":"Orally administered eicosapentaenoic acid reduces and stabilizes atherosclerotic lesions in ApoE-deficient mice","volume":"197","author":"Matsumoto","year":"2008","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.trsl.2015.06.017_bib160","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1476-511X-13-3","article-title":"The influence of EPA and DHA on markers of inflammation in 3T3-L1 cells at\u00a0different stages of cellular maturation","volume":"13","author":"Prostek","year":"2014","journal-title":"Lipids Health Dis"},{"key":"10.1016\/j.trsl.2015.06.017_bib161","first-page":"381","article-title":"Deficiency of essential fatty acids and atherosclerosis, etcetera","volume":"270","author":"Sinclair","year":"1956","journal-title":"Lancet"},{"key":"10.1016\/j.trsl.2015.06.017_bib162","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1056\/NEJM198902023200501","article-title":"The effect of dietary supplementation with n-3 polyunsaturated fatty acids on the synthesis of interleukin-1 and tumor necrosis factor by mononuclear cells","volume":"320","author":"Endres","year":"1989","journal-title":"N Engl J Med"},{"key":"10.1016\/j.trsl.2015.06.017_bib163","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.plefa.2007.10.015","article-title":"Immunomodulation by omega-3 fatty acids","volume":"77","author":"Calder","year":"2007","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"key":"10.1016\/j.trsl.2015.06.017_bib164","doi-asserted-by":"crossref","first-page":"495","DOI":"10.3945\/jn.108.100354","article-title":"DHA supplementation decreases serum C-reactive protein and other markers of inflammation in hypertriglyceridemic men","volume":"139","author":"Kelley","year":"2009","journal-title":"J Nutr"},{"key":"10.1016\/j.trsl.2015.06.017_bib165","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1007\/s00125-005-0053-y","article-title":"Polyunsaturated fatty acids of marine origin induce adiponectin in mice fed a high-fat diet","volume":"49","author":"Flachs","year":"2006","journal-title":"Diabetologia"},{"key":"10.1016\/j.trsl.2015.06.017_bib166","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1038\/nature10798","article-title":"Dysfunction of lipid sensor GPR120 leads to obesity in both mouse and human","volume":"483","author":"Ichimura","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.trsl.2015.06.017_bib167","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/j.cell.2010.07.041","article-title":"GPR120 is an omega-3 fatty acid receptor mediating potent anti-inflammatory and insulin-sensitizing effects","volume":"142","author":"Oh","year":"2010","journal-title":"Cell"},{"key":"10.1016\/j.trsl.2015.06.017_bib168","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.2337\/dc06-1332","article-title":"n-3 fatty acids in the treatment of diabetic patients: biological rationale and clinical data","volume":"30","author":"De Caterina","year":"2007","journal-title":"Diabetes Care"},{"issue":"Suppl 1","key":"10.1016\/j.trsl.2015.06.017_bib169","doi-asserted-by":"crossref","first-page":"S93","DOI":"10.33549\/physiolres.932715","article-title":"The effect of n-3 fatty acids on glucose homeostasis and insulin sensitivity","volume":"63","author":"Flachs","year":"2014","journal-title":"Physiol Res"},{"key":"10.1016\/j.trsl.2015.06.017_bib170","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1111\/j.1365-2125.2012.04374.x","article-title":"Omega-3 polyunsaturated fatty acids and inflammatory processes: nutrition or pharmacology?","volume":"75","author":"Calder","year":"2013","journal-title":"Br J Clin Pharmaco"},{"key":"10.1016\/j.trsl.2015.06.017_bib171","doi-asserted-by":"crossref","first-page":"5408","DOI":"10.4049\/jimmunol.1100225","article-title":"Resolvin D1 and its precursor docosahexaenoic acid promote resolution of adipose tissue inflammation by eliciting macrophage polarization toward an M2-like phenotype","volume":"187","author":"Titos","year":"2011","journal-title":"J Immunol"},{"key":"10.1016\/j.trsl.2015.06.017_bib172","doi-asserted-by":"crossref","first-page":"618","DOI":"10.2337\/db12-0684","article-title":"Proresolution therapy for the treatment of delayed healing of diabetic wounds","volume":"62","author":"Tang","year":"2013","journal-title":"Diabetes"},{"key":"10.1016\/j.trsl.2015.06.017_bib173","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/j.cmet.2014.09.004","article-title":"The arachidonic acid metabolome serves as a conserved regulator of cholesterol metabolism","volume":"20","author":"Demetz","year":"2014","journal-title":"Cell Metab"},{"key":"10.1016\/j.trsl.2015.06.017_bib174","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1097\/00004872-200208000-00010","article-title":"Blood pressure response to fish oil supplementation: metaregression analysis of randomized trials","volume":"20","author":"Geleijnse","year":"2002","journal-title":"J Hypertens"},{"key":"10.1016\/j.trsl.2015.06.017_bib175","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0735-1097(99)00548-3","article-title":"Dietary supplementation with marine omega-3 fatty acids improve systemic large artery endothelial function in subjects with hypercholesterolemia","volume":"35","author":"Goodfellow","year":"2000","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.trsl.2015.06.017_bib176","first-page":"885","article-title":"Long-chain omega-3 fatty acids eicosapentaenoic acid and docosahexaenoic acid and blood pressure: a meta-analysis of randomized controlled trials","volume":"27","author":"Miller","year":"2014","journal-title":"America"},{"key":"10.1016\/j.trsl.2015.06.017_bib177","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1007\/BF00052562","article-title":"Vascular relaxation to omega-3 fatty acids: comparison to sodium nitroprusside, nitroglycerin, papaverine, and D600","volume":"6","author":"Engler","year":"1992","journal-title":"Cardiovasc Drugs Ther"},{"key":"10.1016\/j.trsl.2015.06.017_bib178","first-page":"3086","article-title":"Omega-3 fatty acids: a novel resort against gastrointestinal injury","volume":"18","author":"Ianiro","year":"2014","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"10.1016\/j.trsl.2015.06.017_bib179","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1007\/s10554-010-9616-1","article-title":"Prediction of future cardiovascular outcomes by flow-mediated vasodilatation of brachial artery: a meta-analysis","volume":"26","author":"Inaba","year":"2010","journal-title":"Int J Cardiovasc Imaging"},{"key":"10.1016\/j.trsl.2015.06.017_bib180","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1172\/JCI4829","article-title":"Hypercholesterolemia decreases nitric oxide production by promoting the interaction of caveolin and endothelial nitric oxide synthase","volume":"103","author":"Feron","year":"1999","journal-title":"J Clin Invest"},{"key":"10.1016\/j.trsl.2015.06.017_bib181","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.jnutbio.2010.01.007","article-title":"Docosahexaenoic acid attenuates VCAM-1 expression and NF-kappaB activation in TNF-alpha-treated human aortic endothelial cells","volume":"22","author":"Wang","year":"2011","journal-title":"J Nutral biochemistry"},{"key":"10.1016\/j.trsl.2015.06.017_bib182","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/j.jnutbio.2010.09.013","article-title":"Caveolae: a regulatory platform for nutritional modulation of inflammatory diseases","volume":"22","author":"Layne","year":"2011","journal-title":"J Nutr Biochem"},{"key":"10.1016\/j.trsl.2015.06.017_bib183","first-page":"988","article-title":"Omega-3 supplementation lowers inflammation in healthy middle-aged and older adults: a randomized controlled trial","volume":"26","author":"Kiecolt-Glaser","year":"2012","journal-title":"Brain"},{"key":"10.1016\/j.trsl.2015.06.017_bib184","doi-asserted-by":"crossref","first-page":"415","DOI":"10.3945\/ajcn.2009.27680","article-title":"Fish-oil supplementation induces antiinflammatory gene expression profiles in\u00a0human blood mononuclear cells","volume":"90","author":"Bouwens","year":"2009","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.trsl.2015.06.017_bib185","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1186\/1476-511X-13-196","article-title":"The impact of polyunsaturated fatty acid-based dietary supplements on disease biomarkers in a metabolic syndrome\/diabetes population","volume":"13","author":"Lee","year":"2014","journal-title":"Lipids Health Dis"},{"key":"10.1016\/j.trsl.2015.06.017_bib186","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1161\/ATVBAHA.109.198036","article-title":"Combined therapy of dietary fish oil and stearoyl-CoA desaturase 1 inhibition prevents the metabolic syndrome and atherosclerosis","volume":"30","author":"Brown","year":"2010","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.trsl.2015.06.017_bib187","doi-asserted-by":"crossref","first-page":"2122","DOI":"10.1161\/ATVBAHA.112.253435","article-title":"Omega-3 fatty acids ameliorate atherosclerosis by favorably altering monocyte subsets and limiting monocyte recruitment to aortic lesions","volume":"32","author":"Brown","year":"2012","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.trsl.2015.06.017_bib188","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1194\/jlr.M005058","article-title":"Dietary n-3 LCPUFA from fish oil but not alpha-linolenic acid-derived LCPUFA confers atheroprotection in mice","volume":"51","author":"Degirolamo","year":"2010","journal-title":"J Lipid Res"},{"key":"10.1016\/j.trsl.2015.06.017_bib189","doi-asserted-by":"crossref","first-page":"1963","DOI":"10.1161\/ATVBAHA.111.229443","article-title":"Orally administered eicosapentaenoic acid induces rapid regression of atherosclerosis via modulating the phenotype of dendritic cells in LDL receptor-deficient mice","volume":"31","author":"Nakajima","year":"2011","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.trsl.2015.06.017_bib190","doi-asserted-by":"crossref","first-page":"515","DOI":"10.7326\/0003-4819-158-7-201304020-00003","article-title":"Plasma phospholipid long-chain omega-3 fatty acids and total and cause-specific mortality in older adults: a cohort study","volume":"158","author":"Mozaffarian","year":"2013","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.trsl.2015.06.017_bib191","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.atherosclerosis.2011.05.030","article-title":"Impact of omega-3 polyunsaturated fatty acids on coronary plaque instability: an integrated backscatter intravascular ultrasound study","volume":"218","author":"Amano","year":"2011","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.trsl.2015.06.017_bib192","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/S1567-5688(13)70005-9","article-title":"Long-term effect of high dose omega-3 fatty acid supplementation for secondary prevention of cardiovascular outcomes: A meta-analysis of randomized, placebo controlled trials","volume":"14","author":"Casula","year":"2013","journal-title":"Atheroscler Suppl"},{"key":"10.1016\/j.trsl.2015.06.017_bib193","doi-asserted-by":"crossref","first-page":"e000506","DOI":"10.1161\/JAHA.113.000506","article-title":"Circulating and dietary omega-3 and omega-6 polyunsaturated fatty acids and incidence of CVD in the multi-ethnic study of atherosclerosis","volume":"2","author":"de Oliveira Otto","year":"2013","journal-title":"J\u00a0Am Heart Assoc"},{"key":"10.1016\/j.trsl.2015.06.017_bib194","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/S0140-6736(99)07072-5","article-title":"Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto miocardico","volume":"354","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.trsl.2015.06.017_bib195","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1016\/S0140-6736(07)60527-3","article-title":"Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS): a randomised open-label, blinded endpoint analysis","volume":"369","author":"Yokoyama","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.trsl.2015.06.017_bib196","doi-asserted-by":"crossref","first-page":"31","DOI":"10.2217\/17460875.2.1.31","article-title":"PPAR\u03b1: its role in the human metabolic syndrome","volume":"2","author":"Salman Azhar","year":"2007","journal-title":"Future Lipidol"},{"key":"10.1016\/j.trsl.2015.06.017_bib197","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1016\/j.bbalip.2007.05.003","article-title":"PPARalpha and dyslipidemia","volume":"1771","author":"Duval","year":"2007","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.trsl.2015.06.017_bib198","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.pharmthera.2005.08.007","article-title":"Peroxisome proliferator-activated receptors and inflammation","volume":"110","author":"Moraes","year":"2006","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.trsl.2015.06.017_bib199","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.pharmthera.2009.03.003","article-title":"Significance of peroxisome proliferator-activated receptors in the cardiovascular system in health and disease","volume":"122","author":"Robinson","year":"2009","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.trsl.2015.06.017_bib200","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1161\/CIRCULATIONAHA.104.475673","article-title":"Peroxisome proliferator-activated receptors as transcriptional nodal points and therapeutic targets","volume":"115","author":"Brown","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.trsl.2015.06.017_bib201","doi-asserted-by":"crossref","first-page":"2717","DOI":"10.1194\/jlr.M500326-JLR200","article-title":"Peroxisome proliferator-activated receptor alpha controls cellular cholesterol trafficking in macrophages","volume":"46","author":"Chinetti-Gbaguidi","year":"2005","journal-title":"J Lipid Res"},{"key":"10.1016\/j.trsl.2015.06.017_bib202","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1056\/NEJM198711123172001","article-title":"Helsinki Heart Study: primary-prevention trial with gemfibrozil in middle-aged men with dyslipidemia. Safety of treatment, changes in risk factors, and incidence of coronary heart disease","volume":"317","author":"Frick","year":"1987","journal-title":"N Engl J Med"},{"key":"10.1016\/j.trsl.2015.06.017_bib203","doi-asserted-by":"crossref","first-page":"493","DOI":"10.2337\/dc08-1543","article-title":"Effects of fenofibrate treatment on cardiovascular disease risk in 9,795 individuals with type 2 diabetes and various components of the metabolic syndrome: the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study","volume":"32","author":"Scott","year":"2009","journal-title":"Diabetes Care"},{"key":"10.1016\/j.trsl.2015.06.017_bib204","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1056\/NEJMoa1001282","article-title":"Effects of combination lipid therapy in type 2 diabetes mellitus","volume":"362","author":"Group","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.trsl.2015.06.017_bib205","doi-asserted-by":"crossref","first-page":"2200","DOI":"10.1056\/NEJMoa1400284","article-title":"Targeting APOC3 in the familial chylomicronemia syndrome","volume":"371","author":"Gaudet","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.trsl.2015.06.017_bib206","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1161\/CIRCRESAHA.111.300367","article-title":"Antisense oligonucleotide inhibition of apolipoprotein C-III reduces plasma triglycerides in rodents, nonhuman primates, and humans","volume":"112","author":"Graham","year":"2013","journal-title":"Circ Res"},{"key":"10.1016\/j.trsl.2015.06.017_bib207","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1056\/NEJMoa1300955","article-title":"Effects of extended-release niacin with laropiprant in high-risk patients","volume":"371","author":"Group","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.trsl.2015.06.017_bib208","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1056\/NEJMoa0706628","article-title":"Effects of torcetrapib in patients at high risk for coronary events","volume":"357","author":"Barter","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.trsl.2015.06.017_bib209","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1056\/NEJMoa1107579","article-title":"Niacin in patients with low HDL cholesterol levels receiving intensive statin therapy","volume":"365","author":"Investigators","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.trsl.2015.06.017_bib210","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.jash.2013.02.006","article-title":"Telmisartan as a metabolic sartan: the first meta-analysis of randomized controlled trials in metabolic syndrome","volume":"7","author":"Takagi","year":"2013","journal-title":"J Am Soc Hypertens"},{"key":"10.1016\/j.trsl.2015.06.017_bib211","doi-asserted-by":"crossref","first-page":"4705","DOI":"10.1016\/S0021-9258(17)37600-7","article-title":"Role of transcription factor NF-kappa B\/Rel in induction of nitric oxide synthase","volume":"269","author":"Xie","year":"1994","journal-title":"J Biol Chem"},{"key":"10.1016\/j.trsl.2015.06.017_bib212","doi-asserted-by":"crossref","first-page":"31315","DOI":"10.1074\/jbc.270.52.31315","article-title":"Transcriptional roles of nuclear factor kappa B and nuclear factor-interleukin-6 in the tumor necrosis factor alpha-dependent induction of cyclooxygenase-2 in MC3T3-E1 cells","volume":"270","author":"Yamamoto","year":"1995","journal-title":"J Biol Chem"},{"key":"10.1016\/j.trsl.2015.06.017_bib213","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1161\/01.RES.86.12.1266","article-title":"Angiotensin II activates nuclear transcription factor kappaB through AT(1) and AT(2) in vascular smooth muscle cells: molecular mechanisms","volume":"86","author":"Ruiz-Ortega","year":"2000","journal-title":"Circ Res"},{"key":"10.1016\/j.trsl.2015.06.017_bib214","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1177\/1358863X12450094","article-title":"Link between the renin-angiotensin system and insulin resistance: implications for cardiovascular disease","volume":"17","author":"Zhou","year":"2012","journal-title":"Vascular medicine"},{"key":"10.1016\/j.trsl.2015.06.017_bib215","doi-asserted-by":"crossref","first-page":"12490","DOI":"10.1073\/pnas.93.22.12490","article-title":"Cross-talk between the insulin and angiotensin signaling systems","volume":"93","author":"Velloso","year":"1996","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.trsl.2015.06.017_bib216","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1161\/01.ATV.0000164313.17167.df","article-title":"Mechanisms of reactive oxygen species-dependent downregulation of insulin receptor substrate-1 by angiotensin II","volume":"25","author":"Taniyama","year":"2005","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.trsl.2015.06.017_bib217","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1161\/01.RES.0000126501.34994.96","article-title":"Angiotensin II impairs the insulin signaling pathway promoting production of nitric oxide by inducing phosphorylation of insulin receptor substrate-1 on Ser312 and Ser616 in human umbilical vein endothelial cells","volume":"94","author":"Andreozzi","year":"2004","journal-title":"Circ Res"},{"key":"10.1016\/j.trsl.2015.06.017_bib218","doi-asserted-by":"crossref","first-page":"I29","DOI":"10.1161\/01.HYP.23.1_Suppl.I29","article-title":"Insulin sensitivity and the effects of insulin on renal sodium handling and pressor systems in essential hypertensive patients","volume":"23","author":"Shimamoto","year":"1994","journal-title":"Hypertension"},{"key":"10.1016\/j.trsl.2015.06.017_bib219","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1161\/01.HYP.0000036448.44066.53","article-title":"Angiotensin blockade prevents type 2 diabetes by formation of fat cells","volume":"40","author":"Sharma","year":"2002","journal-title":"Hypertension"},{"key":"10.1016\/j.trsl.2015.06.017_bib220","doi-asserted-by":"crossref","first-page":"517","DOI":"10.4330\/wjc.v6.i7.517","article-title":"Antihypertensive drugs and glucose metabolism","volume":"6","author":"Rizos","year":"2014","journal-title":"World J Cardiol"},{"key":"10.1016\/j.trsl.2015.06.017_bib221","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1056\/NEJM198909283211305","article-title":"A comparison of the effects of hydrochlorothiazide and captopril on glucose and lipid metabolism in patients with hypertension","volume":"321","author":"Pollare","year":"1989","journal-title":"N Engl J Med"},{"key":"10.1016\/j.trsl.2015.06.017_bib222","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/0002-9343(90)90227-5","article-title":"Hypoglycemia induced by angiotensin-converting enzyme inhibitors in patients with non-insulin-dependent diabetes receiving sulfonylurea therapy","volume":"89","author":"Arauz-Pacheco","year":"1990","journal-title":"Am J Med"},{"key":"10.1016\/j.trsl.2015.06.017_bib223","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1016\/S0140-6736(95)91988-0","article-title":"Hypoglycaemia associated with use of inhibitors of angiotensin converting enzyme","volume":"345","author":"Herings","year":"1995","journal-title":"Lancet"},{"key":"10.1016\/j.trsl.2015.06.017_bib224","doi-asserted-by":"crossref","first-page":"e53","DOI":"10.1161\/HYPERTENSIONAHA.113.02426","article-title":"Possible role of angiotensin-converting enzyme 2 and activation of angiotensin II type 2 receptor by angiotensin-(1-7) in improvement of vascular remodeling by angiotensin II type 1 receptor blockade","volume":"63","author":"Ohshima","year":"2014","journal-title":"Hypertension"},{"key":"10.1016\/j.trsl.2015.06.017_bib225","doi-asserted-by":"crossref","first-page":"14948","DOI":"10.1073\/pnas.0903958106","article-title":"Blocking angiotensin-converting enzyme induces potent regulatory T cells and modulates TH1- and TH17-mediated autoimmunity","volume":"106","author":"Platten","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.trsl.2015.06.017_bib226","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbrc.2015.02.087","article-title":"Heat shock transcription factor delta is targeted for degradation via an ubiquitin-like protein ThiS in Escherichia coli","author":"Xu","year":"2015","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.trsl.2015.06.017_bib227","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.atherosclerosis.2008.04.010","article-title":"Candesartan inhibits Toll-like receptor expression and activity both in\u00a0vitro and in\u00a0vivo","volume":"202","author":"Dasu","year":"2009","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.trsl.2015.06.017_bib228","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1161\/01.HYP.0000154361.47683.d3","article-title":"Weight loss and the renin-angiotensin-aldosterone system","volume":"45","author":"Engeli","year":"2005","journal-title":"Hypertension"},{"key":"10.1016\/j.trsl.2015.06.017_bib229","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1056\/NEJM198104163041602","article-title":"The effect of weight reduction on blood pressure, plasma renin activity, and plasma aldosterone levels in obese patients","volume":"304","author":"Tuck","year":"1981","journal-title":"N Engl J Med"},{"key":"10.1016\/j.trsl.2015.06.017_bib230","doi-asserted-by":"crossref","first-page":"3481","DOI":"10.1210\/en.2005-0003","article-title":"Attenuation of diet-induced weight gain and adiposity through increased energy expenditure in mice lacking angiotensin II type 1a receptor","volume":"146","author":"Kouyama","year":"2005","journal-title":"Endocrinology"},{"key":"10.1016\/j.trsl.2015.06.017_bib231","doi-asserted-by":"crossref","first-page":"991","DOI":"10.2337\/diabetes.54.4.991","article-title":"Deletion of the angiotensin type 2 receptor (AT2R) reduces adipose cell size and protects from diet-induced obesity and insulin resistance","volume":"54","author":"Yvan-Charvet","year":"2005","journal-title":"Diabetes"},{"key":"10.1016\/j.trsl.2015.06.017_bib232","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1161\/HYPERTENSIONAHA.107.095489","article-title":"Aldosterone and vascular inflammation","volume":"51","author":"Brown","year":"2008","journal-title":"Hypertension"},{"key":"10.1016\/j.trsl.2015.06.017_bib233","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.1096\/fj.06-7970com","article-title":"Pivotal role of the mineralocorticoid receptor in corticosteroid-induced adipogenesis","volume":"21","author":"Caprio","year":"2007","journal-title":"FASEB J"},{"key":"10.1016\/j.trsl.2015.06.017_bib234","doi-asserted-by":"crossref","first-page":"2253","DOI":"10.1161\/CIRCULATIONAHA.107.748640","article-title":"Mineralocorticoid receptor blockade reverses obesity-related changes in expression of adiponectin, peroxisome proliferator-activated receptor-gamma, and proinflammatory adipokines","volume":"117","author":"Guo","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.trsl.2015.06.017_bib235","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1161\/CIRCRESAHA.108.174235","article-title":"Functional mineralocorticoid receptors in human vascular endothelial cells regulate intercellular adhesion molecule-1 expression and promote leukocyte adhesion","volume":"102","author":"Caprio","year":"2008","journal-title":"Circ Res"},{"key":"10.1016\/j.trsl.2015.06.017_bib236","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/S0960-0760(03)00072-4","article-title":"Transcriptional inhibition of the human insulin receptor gene by aldosterone","volume":"84","author":"Calle","year":"2003","journal-title":"J Steroid Biochem Mol Biol"},{"key":"10.1016\/j.trsl.2015.06.017_bib237","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1093\/cvr\/cvp191","article-title":"Blockade of mineralocorticoid receptor reverses adipocyte dysfunction and insulin resistance in obese mice","volume":"84","author":"Hirata","year":"2009","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.trsl.2015.06.017_bib238","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1161\/HYPERTENSIONAHA.107.093955","article-title":"Aldosterone suppresses insulin signaling via the downregulation of insulin receptor substrate-1 in vascular smooth muscle cells","volume":"50","author":"Hitomi","year":"2007","journal-title":"Hypertension"},{"key":"10.1016\/j.trsl.2015.06.017_bib239","doi-asserted-by":"crossref","first-page":"2040","DOI":"10.1210\/en.2009-0869","article-title":"Spironolactone improves glucose and lipid metabolism by ameliorating hepatic steatosis and inflammation and suppressing enhanced gluconeogenesis induced by high-fat and high-fructose diet","volume":"151","author":"Wada","year":"2010","journal-title":"Endocrinology"},{"key":"10.1016\/j.trsl.2015.06.017_bib240","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1038\/jhh.2009.81","article-title":"Clinical effects of eplerenone, a selective aldosterone blocker, in Japanese patients with essential hypertension","volume":"24","author":"Sato","year":"2010","journal-title":"J Hum Hypertens"},{"key":"10.1016\/j.trsl.2015.06.017_bib241","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa1009492","article-title":"Eplerenone in patients with systolic heart failure and mild symptoms","volume":"364","author":"Zannad","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.trsl.2015.06.017_bib242","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1016\/S0140-6736(10)61350-5","article-title":"Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials","volume":"376","author":"Baigent","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.trsl.2015.06.017_bib243","doi-asserted-by":"crossref","first-page":"2491","DOI":"10.1016\/j.jacc.2014.01.054","article-title":"Innate and adaptive inflammation as a therapeutic target in vascular disease: the emerging role of statins","volume":"63","author":"Tousoulis","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.trsl.2015.06.017_bib244","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1161\/01.ATV.0000168410.44722.86","article-title":"Statins decrease Toll-like receptor 4 expression and downstream signaling in human CD14+ monocytes","volume":"25","author":"Methe","year":"2005","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.trsl.2015.06.017_bib245","doi-asserted-by":"crossref","first-page":"4229","DOI":"10.2174\/138161206778743501","article-title":"Endotoxin, TLR4 signaling and vascular inflammation: potential therapeutic targets in cardiovascular disease","volume":"12","author":"Stoll","year":"2006","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.trsl.2015.06.017_bib246","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.atherosclerosis.2005.12.022","article-title":"Simvastatin suppresses endotoxin-induced upregulation of toll-like receptors 4 and 2 in\u00a0vivo","volume":"189","author":"Niessner","year":"2006","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.trsl.2015.06.017_bib247","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1161\/01.ATV.0000063385.12476.A7","article-title":"Endothelium-dependent effects of statins","volume":"23","author":"Wolfrum","year":"2003","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.trsl.2015.06.017_bib248","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1136\/hrt.2006.088211","article-title":"Assessing inflammatory status in cardiovascular disease","volume":"93","author":"Tousoulis","year":"2007","journal-title":"Heart"},{"key":"10.1016\/j.trsl.2015.06.017_bib249","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1161\/01.CIR.103.3.357","article-title":"Pravastatin and the development of diabetes mellitus: evidence for a protective treatment effect in the West of Scotland Coronary Prevention Study","volume":"103","author":"Freeman","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.trsl.2015.06.017_bib250","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/S0140-6736(09)61965-6","article-title":"Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials","volume":"375","author":"Sattar","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.trsl.2015.06.017_bib251","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1007\/s11883-014-0472-7","article-title":"Pathogenesis and management of the diabetogenic effect of statins: a role for adiponectin and coenzyme Q10?","volume":"17","author":"Chan","year":"2015","journal-title":"Curr Atheroscler Rep"},{"key":"10.1016\/j.trsl.2015.06.017_bib252","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1007\/s00125-006-0269-5","article-title":"Effects of statins on the adipocyte maturation and expression of glucose transporter 4 (SLC2A4): implications in glycaemic control","volume":"49","author":"Nakata","year":"2006","journal-title":"Diabetologia"},{"key":"10.1016\/j.trsl.2015.06.017_bib253","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1016\/j.amjcard.2007.06.028","article-title":"Simvastatin (40 mg\/day), adiponectin levels, and insulin sensitivity in subjects with the metabolic syndrome","volume":"100","author":"Devaraj","year":"2007","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.trsl.2015.06.017_bib254","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.metabol.2006.11.007","article-title":"Effect of simvastatin and\/or pioglitazone on insulin resistance, insulin secretion, adiponectin, and proinsulin levels in nondiabetic patients at cardiovascular risk\u2013the PIOSTAT Study","volume":"56","author":"Forst","year":"2007","journal-title":"Metabolism"},{"key":"10.1016\/j.trsl.2015.06.017_bib255","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1253\/circj.71.144","article-title":"Differential impact of atorvastatin vs pravastatin on progressive insulin resistance and left ventricular diastolic dysfunction in a rat model of type II diabetes","volume":"71","author":"Chen","year":"2007","journal-title":"Circ J"},{"key":"10.1016\/j.trsl.2015.06.017_bib256","first-page":"675","article-title":"Plasma coenzyme Q10 levels in type 2 diabetic patients with retinopathy","volume":"6","author":"Ates","year":"2013","journal-title":"Int J Ophthalmol"},{"key":"10.1016\/j.trsl.2015.06.017_bib257","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1054\/mehy.1997.0681","article-title":"Can correction of sub-optimal coenzyme Q status improve beta-cell function in type II diabetics?","volume":"52","author":"McCarty","year":"1999","journal-title":"Med Hypotheses"},{"key":"10.1016\/j.trsl.2015.06.017_bib258","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/978-90-481-3271-3_9","article-title":"Role of mitochondria in beta-cell function and dysfunction","volume":"654","author":"Maechler","year":"2010","journal-title":"Adv Exp Med Biol"},{"issue":"Suppl","key":"10.1016\/j.trsl.2015.06.017_bib259","doi-asserted-by":"crossref","first-page":"S168","DOI":"10.1016\/j.mito.2007.03.002","article-title":"Coenzyme Q10 and statins: biochemical and clinical implications","volume":"7","author":"Littarru","year":"2007","journal-title":"Mitochondrion"}],"container-title":["Translational Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1931524415002224?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1931524415002224?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,5,17]],"date-time":"2022-05-17T17:06:20Z","timestamp":1652807180000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1931524415002224"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,1]]},"references-count":259,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,1]]}},"alternative-id":["S1931524415002224"],"URL":"https:\/\/doi.org\/10.1016\/j.trsl.2015.06.017","relation":{},"ISSN":["1931-5244"],"issn-type":[{"value":"1931-5244","type":"print"}],"subject":[],"published":{"date-parts":[[2016,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeting inflammation in metabolic syndrome","name":"articletitle","label":"Article Title"},{"value":"Translational Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.trsl.2015.06.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}